A Study to Learn About the Effect of Avelumab First-Line Maintenance in Canadian People With Advanced Bladder Cancer
- Status
- TERMINATED
- Phase
- N/A
Clinical Trials Related to Urothelial Carcinoma
Related studies linked through entity extraction aliases.
A Study to Investigate the Antitumor Activity, Safety, Tolerability, and Pharmacokinetics of BGB-A445 in Combination With Tislelizumab in Participants With Select Advanced Solid Tumors.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Bladder Cancer Screening Trial
- Status
- RECRUITING
- Phase
- NA
Study of JK08 in Patients with Unresectable Locally Advanced or Metastatic Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Chemotherapy and Sequential Immunotherapy for Locally Advanced Urothelial Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Phase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Phase II Trial of Lurbinectedin Combined With Avelumab as Switch Maintenance Firstline Therapy
- Status
- WITHDRAWN
- Phase
- PHASE2
Testing Anti-Cancer Drugs Erdafitinib With or Without Atezolizumab in Patients With Localized Bladder Cancer Not Able to Receive Cisplatin Chemotherapy, NERA Trial
- Status
- WITHDRAWN
- Phase
- PHASE2
A Substudy of Investigational Agents in Programmed Cell Death-1/Ligand 1 (PD-1/L1) Refractory Locally Advanced or Metastatic Urothelial Carcinoma (mUC) (MK-3475-04A)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Safety and Preliminary Anti-Tumor Activity of TYRA-300 in Advanced Urothelial Carcinoma and Other Solid Tumors With FGFR3 Gene Alterations
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Evorpacept (ALX148) With Enfortumab Vedotin for Subjects With Urothelial Carcinoma (ASPEN-07)
- Status
- COMPLETED
- Phase
- PHASE1
PSMA Expression and PSMA PET Imaging in Soft Tissue Sarcomas and Urothelial Cell Carcinomas
- Status
- COMPLETED
- Phase
- NA
A Study of Nivolumab Intravenous (IV) to Subcutaneous (SC) Switch in Adjuvant Melanoma and Bladder Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Named Patient Program for Mitomycin for Pyelocalyceal Solution
- Status
- AVAILABLE
- Phase
- N/A
A Study to Learn About the Study Medicine (Avelumab) in Japanese Patients With Urothelial Carcinoma That Has Spread
- Status
- COMPLETED
- Phase
- N/A
Pembrolizumab in Muscle-invasive Bladder Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Multicenter Clinical Trial of Urine DNA Testing for Bladder Cancer in China
- Status
- RECRUITING
- Phase
- N/A
A Phase 2 Study to Evaluate the Triplet Combination of Pemetrexed Plus AB928 (Etrumadenant) + AB122 (Zimberelimab) in Patients With Previously Treated Advanced or Metastatic MTAP Deficient Urothelial Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Nectin-4 Specific LMW PET Probe Imaging in Urothelial Carcinoma
- Status
- RECRUITING
- Phase
- NA